In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents.

In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry.

Links:

Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others.

Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities.

Learn more about Advisory Board Fellowship.

A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

200: Why 2024 is a make-or-break year for corporate medical groups

Radio Advisory